Year |
Citation |
Score |
2023 |
Kirk MJ, Gold A, Ravi A, Sterne GR, Scott K, Miller EW. Cell-Surface Targeting of Fluorophores in for Rapid Neuroanatomy Visualization. Acs Chemical Neuroscience. PMID 36799505 DOI: 10.1021/acschemneuro.2c00745 |
0.602 |
|
2021 |
Kirk MJ, Benlian BR, Han Y, Gold A, Ravi A, Deal PE, Molina RS, Drobizhev M, Dickman D, Scott K, Miller EW. Voltage Imaging in Using a Hybrid Chemical-Genetic Rhodamine Voltage Reporter. Frontiers in Neuroscience. 15: 754027. PMID 34867164 DOI: 10.3389/fnins.2021.754027 |
0.51 |
|
2021 |
Raliski BK, Kirk MJ, Miller EW. Imaging Spontaneous Neuronal Activity with Voltage-Sensitive Dyes. Current Protocols. 1: e48. PMID 33760396 DOI: 10.1002/cpz1.48 |
0.59 |
|
2020 |
Kirk MJ, Raliski BK, Miller EW. Monitoring neuronal activity with voltage-sensitive fluorophores. Methods in Enzymology. 640: 185-204. PMID 32560798 DOI: 10.1016/Bs.Mie.2020.04.028 |
0.627 |
|
2019 |
Wegmann S, Bennett RE, Delorme L, Robbins AB, Hu M, McKenzie D, Kirk MJ, Schiantarelli J, Tunio N, Amaral AC, Fan Z, Nicholls S, Hudry E, Hyman BT. Experimental evidence for the age dependence of tau protein spread in the brain. Science Advances. 5: eaaw6404. PMID 31249873 DOI: 10.1126/Sciadv.Aaw6404 |
0.503 |
|
2015 |
Wegmann S, Maury EA, Kirk MJ, Saqran L, Roe A, DeVos SL, Nicholls S, Fan Z, Takeda S, Cagsal-Getkin O, William CM, Spires-Jones TL, Pitstick R, Carlson GA, Pooler AM, et al. Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity. The Embo Journal. PMID 26538322 DOI: 10.15252/Embj.201592748 |
0.485 |
|
2015 |
Wegmann S, Maury EA, Kirk MJ, Saqran L, Roe AD, Fan Z, Nicholls SB, DeVos SL, Takeda S, William CM, Spires-Jones TL, Pitstick R, Carlson GA, Pooler A, Hyman BT. O2-06-01: Lack of endogenous tau permits tau spreading and protects against tau toxicity in transgenic mice Alzheimer's & Dementia. 11: P186-P186. DOI: 10.1016/J.Jalz.2015.07.159 |
0.4 |
|
2014 |
Izzo NJ, Xu J, Zeng C, Kirk MJ, Mozzoni K, Silky C, Rehak C, Yurko R, Look G, Rishton G, Safferstein H, Cruchaga C, Goate A, Cahill MA, Arancio O, et al. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity. Plos One. 9: e111899. PMID 25390692 DOI: 10.1371/Journal.Pone.0111899 |
0.377 |
|
Show low-probability matches. |